WAMIF: Prospective Study in Young Women Presenting Acute Myocardial Infarction: Cohort Follow up
Recruiting
Observational Study
Myocardial Infarction, Acute
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 60
- Sex
- Female
- Study type
- Observational
- Participants needed
- 314 (estimated)
- Sponsor
- French Cardiology Society · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The WAMIF study was conducted from 2017 to 2019, including 314 patients in 30 French research centers spread across metropolitan France. It systematically collected the clinical, morphological, and biological characteristics of myocardial infarction cases affecting women under 50 years of age and assessed their short-term (in-hospital) and medium-term (12-month) prognosis. Extending the follow-up …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
All patients who participated in the WAMIF study (research registration number with the French Ministry of Health : 2015-A01263-46 / Protocol registration with Clinical Trials NCT03073447) and wish to continue follow-up in the study.
Contacts